A prospective ,single arm, open study of Mesylate Apatinib combined with FOLFOX in the treatment of advanced colorectal cancer

ABSTRACT: Interventions: Case series:Mesylate Apatinib Primary outcome(s): R0 resection rate;AE Study Design: Case series

DISEASE(S): Colorectal Cancer

PROVIDER: 2676351 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR